FDA Inspection
Avioq, Inc.Avioq, Inc. – FDA Inspection, May 14, 2026
Record Details
This FDA Inspection record concerns Avioq, Inc., with an inspection on May 14, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 0d209914-3ac7-4bbb-8c7d-c50932a9e33d
Inspection Facts
- Inspection number
- 1305580
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- ISO 13485:2016 Clause 7.1Records of risk management activities in product realization not maintained
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Avioq, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 27, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 17, 2017 | Not classified | Atlanta District Office | |
| January 13, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 27, 2015 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Avioq, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.